Expression pattern of human SERPINE2 in a variety of human tumors

  • Authors:
    • Ying Yang
    • Xiangke Xin
    • Xing Fu
    • Danmei Xu
  • View Affiliations

  • Published online on: January 18, 2018     https://doi.org/10.3892/ol.2018.7819
  • Pages: 4523-4530
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Serine proteinase inhibitor, clade E member 2 (SERPINE2), also known as protease nexin‑1 (PN‑1), is a member of the serpin family. Despite several reported roles of SERPINE2 in tumor development the histological distribution of SERPINE2 and its expression levels in a large variety of tumors remains unclear. Through expressed sequence tag database analysis, immunohistochemical staining of tissue microarrays and a literature review, it was revealed that SERPINE2 expression varied according to growth stages and tissue types. SERPINE2 is differentially expressed in a number of tumors and their normal tissue counterparts. SERPINE2 is identified most abundantly in adenocarcinomas. SERPINE2 serves diverse roles in a variety of tumors and therefore may serve as a promising biomarker for tumor diagnosis and prognosis.

References

1 

Barde YA, Lindsay RM, Monard D and Thoenen H: New factor released by cultured glioma cells supporting survival and growth of sensory neurones. Nature. 274:8181978. View Article : Google Scholar : PubMed/NCBI

2 

Guenther J, Nick H and Monard D: A glia-derived neurite-promoting factor with protease inhibitory activity. EMBO J. 4:1963–1966. 1985.PubMed/NCBI

3 

Stone SR, Nick H, Hofsteenge J and Monard D: Glial-derived neurite-promoting factor is a slow-binding inhibitor of trypsin, thrombin and urokinase. Arch Biochem Biophys. 252:237–244. 1987. View Article : Google Scholar : PubMed/NCBI

4 

Gloor S, Odink K, Guenther J, Nick H and Monard D: A glia-derived neurite promoting factor with protease inhibitory activity belongs to the protease nexins. Cell. 47:687–693. 1986. View Article : Google Scholar : PubMed/NCBI

5 

Mansilla S, Boulaftali Y, Venisse L, Arocas V, Meilhac O, Michel JB, Jandrot-Perrus M and Bouton MC: Macrophages and platelets are the major source of protease nexin-1 in human atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 28:1844–1850. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Fayard B, Bianchi F, Dey J, Moreno E, Djaffer S, Hynes NE and Monard D: The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Cancer Res. 69:5690–5698. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Rosenblatt DE, Cotman CW, Nieto-Sampedro M, Rowe JW and Knauer DJ: Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res. 415:40–48. 1987. View Article : Google Scholar : PubMed/NCBI

8 

McKee CM, Ding Y, Zhou J, Li C, Huang L, Xin X, He J, Allen JE, El-Deiry WS, Cao Y, et al: Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. Oncotarget. 6:3784–3796. 2015. View Article : Google Scholar : PubMed/NCBI

9 

Santoro A, Conde J, Scotece M, Abella V, Lois A, Lopez V, Pino J, Gomez R, Gomez-Reino JJ and Gualillo O: SERPINE2 Inhibits IL-1α-Induced MMP-13 Expression in Human Chondrocytes: Involvement of ERK/NF-κB/AP-1 Pathways. PLoS One. 10:e01359792015. View Article : Google Scholar : PubMed/NCBI

10 

Crisp RJ, Knauer DJ and Knauer MF: Roles of the heparin and low density lipid receptor-related protein-binding sites of protease nexin 1 (PN1) in urokinase-PN1 complex catabolism. The PN1 heparin-binding site mediates complex retention and degradation but not cell surface binding or internalization. J Biol Chem. 275:19628–19637. 2000. View Article : Google Scholar : PubMed/NCBI

11 

Boulaftali Y, Ho-Tin-Noe B, Pena A, Loyau S, Venisse L, François D, Richard B, Arocas V, Collet JP, Jandrot-Perrus M and Bouton MC: Platelet protease nexin-1, a serpin that strongly influences fibrinolysis and thrombolysis. Circulation. 123:1326–1334. 2011. View Article : Google Scholar : PubMed/NCBI

12 

Kitamura K and Tomita K: Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors. Clin Exp Nephrol. 14:405–410. 2010. View Article : Google Scholar : PubMed/NCBI

13 

Zheng D, Chen H, Davids J, Bryant M and Lucas A: Serpins for diagnosis and therapy in cancer. Cardiovasc Hematol Disord Drug Targets. 13:123–132. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Buchholz M, Biebl A, Neesse A, Wagner M, Iwamura T, Leder G, Adler G and Gress TM: SERPINE2 (protease nexin I) promotes extracellular matrix production and local invasion of pancreatic tumors in vivo. Cancer Res. 63:4945–4951. 2003.PubMed/NCBI

15 

Bergeron S, Lemieux E, Durand V, Cagnol S, Carrier JC, Lussier JG, Boucher MJ and Rivard N: The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis. Mol Cancer. 9:2712010. View Article : Google Scholar : PubMed/NCBI

16 

Wang K, Wang B, Xing AY, Xu KS, Li GX and Yu ZH: Prognostic significance of SERPINE2 in gastric cancer and its biological function in SGC7901 cells. J Cancer Res Clin Oncol. 141:805–812. 2015. View Article : Google Scholar : PubMed/NCBI

17 

Stępień T, Brożyna M, Kuzdak K, Motylewska E, Komorowski J, Stępień H and Ławnicka H: Elevated concentrations of SERPINE2/protease nexin-1 and secretory leukocyte protease inhibitor in the serum of patients with papillary thyroid cancer. Dis Markers. 2017:49621372017. View Article : Google Scholar : PubMed/NCBI

18 

Gao S, Krogdahl A, Sørensen JA, Kousted TM, Dabelsteen E and Andreasen PA: Overexpression of protease nexin-1 mRNA and protein in oral squamous cell carcinomas. Oral Oncol. 44:309–313. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Mao M and Wang W: SerpinE2 promotes multiple cell proliferation and drug resistance in osteosarcoma. Mol Med Rep. 14:881–887. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Nagahara A, Nakayama M, Oka D, Tsuchiya M, Kawashima A, Mukai M, Nakai Y, Takayama H, Nishimura K, Jo Y, et al: SERPINE2 is a possible candidate promotor for lymph node metastasis in testicular cancer. Biochem Biophys Res Commun. 391:1641–1646. 2010. View Article : Google Scholar : PubMed/NCBI

21 

McKee CM, Xu D, Cao Y, Kabraji S, Allen D, Kersemans V, Beech J, Smart S, Hamdy F, Ishkanian A, et al: Protease nexin 1 inhibits hedgehog signaling in prostate adenocarcinoma. J Clin Invest. 122:4025–4036. 2012. View Article : Google Scholar : PubMed/NCBI

22 

Xu D, McKee CM, Cao Y, Ding Y, Kessler BM and Muschel RJ: Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res. 70:6988–6998. 2010. View Article : Google Scholar : PubMed/NCBI

23 

McKee CM, Xu D and Muschel RJ: Protease nexin 1: A novel regulator of prostate cancer cell growth and neo-angiogenesis. Oncotarget. 4:1–2. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Pagliara V, Adornetto A, Mammi M, Masullo M, Sarnataro D, Pietropaolo C and Arcone R: Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase plasminogen activator and matrix metalloproteinase-9/2. Biochim Biophys Acta. 1843:2631–2644. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Vaillant C, Valdivieso P, Nuciforo S, Kool M, Schwarzentruber-Schauerte A, Méreau H, Cabuy E, Lobrinus JA, Pfister S, Zuniga A, et al: Serpine2/PN-1 is required for proliferative expansion of pre-neoplastic lesions and malignant progression to medulloblastoma. PLoS One. 10:e01248702015. View Article : Google Scholar : PubMed/NCBI

26 

Boguski MS and Schuler GD: ESTablishing a human transcript map. Nat Genet. 10:369–371. 1995. View Article : Google Scholar : PubMed/NCBI

27 

Selbonne S, Azibani F, Iatmanen S, Boulaftali Y, Richard B, Jandrot-Perrus M, Bouton MC and Arocas V: In vitro and in vivo antiangiogenic properties of the serpin protease nexin-1. Mol Cell Biol. 32:1496–1505. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Selbonne S, Francois D, Raoul W, Boulaftali Y, Sennlaub F, Jandrot-Perrus M, Bouton MC and Arocas V: Protease nexin-1 regulates retinal vascular development. Cell Mol Life Sci. 72:3999–4011. 2015. View Article : Google Scholar : PubMed/NCBI

29 

Li X, Herz J and Monard D: Activation of ERK signaling upon alternative protease nexin-1 internalization mediated by syndecan-1. J Cell Biochem. 99:936–951. 2006. View Article : Google Scholar : PubMed/NCBI

30 

Xu D, Suenaga N, Edelmann MJ, Fridman R, Muschel RJ and Kessler BM: Novel MMP-9 substrates in cancer cells revealed by a label-free quantitative proteomics approach. Mol Cell Proteomics. 7:2215–2228. 2008. View Article : Google Scholar : PubMed/NCBI

31 

Chern SR, Li SH, Lu CH and Chen EI: Spatiotemporal expression of the serine protease inhibitor, SERPINE2, in the mouse placenta and uterus during the estrous cycle, pregnancy, and lactation. Reprod Biol Endocrinol. 8:1272010. View Article : Google Scholar : PubMed/NCBI

32 

Lee RK, Fan CC, Hwu YM, Lu CH, Lin MH, Chen YJ and Li SH: SERPINE2, an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase. Reprod Biol Endocrinol. 9:382011. View Article : Google Scholar : PubMed/NCBI

33 

Lu CH, Lee RK, Hwu YM, Lin MH, Yeh LY, Chen YJ, Lin SP and Li SH: Involvement of the serine protease inhibitor, SERPINE2, and the urokinase plasminogen activator in cumulus expansion and oocyte maturation. PLoS One. 8:e746022013. View Article : Google Scholar : PubMed/NCBI

34 

Koshimizu H, Cawley NX, Kim T, Yergey AL and Loh YP: Serpinin: A novel chromogranin A-derived, secreted peptide up-regulates protease nexin-1 expression and granule biogenesis in endocrine cells. Mol Endocrinol. 25:732–744. 2011. View Article : Google Scholar : PubMed/NCBI

35 

Martin KJ, Patrick DR, Bissell MJ and Fournier MV: Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets. PLoS One. 3:e29942008. View Article : Google Scholar : PubMed/NCBI

36 

Li Y and Lu YY: Applying a highly specific and reproducible cDNA RDA method to clone garlic up-regulated genes in human gastric cancer cells. World J Gastroenterol. 8:213–216. 2002. View Article : Google Scholar : PubMed/NCBI

37 

Selzer-Plon J, Bornholdt J, Friis S, Bisgaard HC, Lothe IM, Tveit KM, Kure EH, Vogel U and Vogel LK: Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis. BMC Cancer. 9:2012009. View Article : Google Scholar : PubMed/NCBI

38 

Cavanaugh KP, Gurwitz D, Cunningham DD and Bradshaw RA: Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J Neurochem. 54:1735–1743. 1990. View Article : Google Scholar : PubMed/NCBI

39 

Lindner J, Guenther J, Nick H, Zinser G, Antonicek H, Schachner M and Monard D: Modulation of granule cell migration by a glia-derived protein. Proc Natl Acad Sci USA. 83:pp. 4568–4571. 1986; View Article : Google Scholar : PubMed/NCBI

40 

Mirante O, Price M, Puentes W, Castillo X, Benakis C, Thevenet J, Monard D and Hirt L: Endogenous protease nexin-1 protects against cerebral ischemia. Int J Mol Sci. 14:16719–16731. 2013. View Article : Google Scholar : PubMed/NCBI

41 

Vaillant C, Michos O, Orolicki S, Brellier F, Taieb S, Moreno E, Té H, Zeller R and Monard D: Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development. Development. 134:1745–1754. 2007. View Article : Google Scholar : PubMed/NCBI

42 

Wu H, Zhao R, Qi J, Cong Y, Wang D, Liu T, Gu Y, Ban X and Huang Q: The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage. J Neurol Sci. 270:172–183. 2008. View Article : Google Scholar : PubMed/NCBI

43 

Vaughan PJ, Su J, Cotman CW and Cunningham DD: Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res. 668:160–170. 1994. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yang, Y., Xin, X., Fu, X., & Xu, D. (2018). Expression pattern of human SERPINE2 in a variety of human tumors. Oncology Letters, 15, 4523-4530. https://doi.org/10.3892/ol.2018.7819
MLA
Yang, Y., Xin, X., Fu, X., Xu, D."Expression pattern of human SERPINE2 in a variety of human tumors". Oncology Letters 15.4 (2018): 4523-4530.
Chicago
Yang, Y., Xin, X., Fu, X., Xu, D."Expression pattern of human SERPINE2 in a variety of human tumors". Oncology Letters 15, no. 4 (2018): 4523-4530. https://doi.org/10.3892/ol.2018.7819